Not sure which big Pharma will be interested in this device, a device company maybe
noted Wilson’s recent report more cautious target now 25c and says what a number of us have said before that their current data is limited and lacks statistical clout (their words) and they’ll need RCT for US approval and wider reimbursement. Wilson’s think 200 sample size over 3.5 years. don’t know how theyve estimated that but I guess that’s possible maybe best case. But OSL need seriously more cash in bank to run such a study.
Not sure which big Pharma will be interested in this device, a...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(11.1%) |
Mkt cap ! $13.32M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $23.68K | 4.971M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 23118264 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 5200224 | 7 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |